Cytochrome c oxidase subunit VIc pseudogene 13 (COX6CP13)

Cytochrome c oxidase subunit 6C pseudogene 13 (COX6CP13) is a non-functional genomic fragment derived from the COX6C gene, which normally encodes a structural subunit of mitochondrial cytochrome c oxidase (complex IV) involved in electron transport and ATP synthesis[1][3][5]. Pseudogenes like COX6CP13 arise through distinct biogenetic processes—such as DNA duplication or retrotransposition—and generally lack protein-coding capacity due to mutations or the absence of regulatory elements[4]. While the parental COX6C gene is implicated in diseases such as cancer, metabolic and mitochondrial disorders, the pseudogene COX6CP13 has no direct enzymatic or receptor functions in these pathways[1][2][3][5]. Pseudogenes can, however, participate in gene regulation through non-coding RNA interactions and provide useful diagnostic information in certain tumor subtypes, but no evidence supports COX6CP13 as a therapeutic target or a primary disease biomarker[2][4][6].

Other names

Cytochrome c oxidase subunit 6C pseudogene 13COX6CP13cytochrome c oxidase subunit VIc pseudogene 13